# Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study

> **NCT01823159** · PHASE3 · COMPLETED · sponsor: **University Hospital of Mont-Godinne** · enrollment: 15 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** retigabine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01823159
- **Lead sponsor:** University Hospital of Mont-Godinne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823159, "Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01823159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*